LICENSE AGREEMENTLicense Agreement • May 9th, 2018 • Compugen LTD • Biological products, (no disgnostic substances)
This License Agreement (the “Agreement”) is entered into as of March 30, 2018 (the “Effective Date”), by and between Compugen Ltd., an Israeli company, having an address of Azrieli Center, 26 Harokmim Street, Building D, Holon 5885849, Israel (“Compugen”), and MedImmune, Limited, a company incorporated in England and a member of the AstraZeneca Group having an address of Milstein Building, Granta Park, Abington, Cambridge, CB21 6GH (“MedImmune”). Compugen and MedImmune may be referred to herein individually as a “Party” or collectively as the “Parties”.
